Acarbose in NIDDM patients with poor control on conventional oral agents: A 24-week placebo-controlled study

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1154-1158

  Lam, Karen S L ^a   Tiu, S C ^b   Tsang, M W ^c   Ip, T P ^a   Tam, Sidney C F ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLATULENCE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ACARBOSE; ADMINISTRATION, ORAL; BLOOD GLUCOSE; CHINA; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FASTING; FEMALE; FLATULENCE; GASTROINTESTINAL DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HONG KONG; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; PATIENT COMPLIANCE; PLACEBOS; POSTPRANDIAL PERIOD; SULFONYLUREA COMPOUNDS; TRANSAMINASES; TREATMENT OUTCOME; TRIGLYCERIDES; TRISACCHARIDES;

EID: 0031850851     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1154     Document Type: Article

References (17)

1. Genuth S: Insulin use in NIDDM. Diabetes Care 13:1240-1264, 1990
2. Balfour JA, McTavish D: Acarbose: an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025-1054, 1993
3. Hoffmann J, Spengler M: Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients: the Essen Study Diabetes Care 17:561-566, 1994
4. Coniff R, Krol A: Acarbose: a review of US clinical experience. Clin Ther 19:16-26, 1997
5. Chiasson J-L, Josse R, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TMS: The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus: a multicenter controlled clinical trial. Ann Intern Med 121:928-935, 1994
6. Coniff RF, Shapiro JA, Seaton TB, Bray GA: Multicenter, placebo-controlled trial comparing acarbose (BAY g5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependem diabetes mellitus. Am J Med 98:443-451, 1995
7. Hollander P, Pi-Sunyer X, Coniff RF: Acarbose in the treatment of type I diabetes. Diabetes Care 20:248-253, 1997
8. Reaven GM, Lardinois CK, Greenfield MS, Schwartz HC, Vreman HJ: Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulphonylurea. Diabetes Care 13 (Suppl. 3):32-36, 1990
9. Bayraktar M, Van Thiel DH, Adalar N: A comparison of acarbose versus metformin as an adjuvant therapy in sulphonylureatreated NIDDM patients. Diabetes Care 19:252-254, 1996
10. Baron A, Neumann C: PROTECT interim results: a large multicenter study of patients with type II diabetes. Clin Ther 19:282-295, 1997
11. Rodier M, Richard JL, Monnier L, Mirouze J: Effect of long term acarbose (BAY g5421) therapy on metabolic control of non-insulin-dependent (type II) diabetes mellitus. Diabete Metab 14:12-14, 1988
12. Lam KSL, Cheng IKR, Janus ED, Pang RWC: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38:604-609, 1995
13. Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fucker K: Therapeutic potentials of acarbose as firstline drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14:732-737, 1991
14. Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB: Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: a placebo-controlled dose-comparison study. Diabetes Care 18:817-824, 1995
15. Jenney A, Proietto J, O'Dea K, Nankervis A, Traianedes K, D'Embden H: Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity. Diabetes Care 16:499-502, 1993
16. Porikos KP, Van Italie TB: Diet induced changes in serum transaminase and triglyceride levels in healthy adult men: role of sucrose and excess calories. Am J Med 75:624-630, 1983
17. Carrascosa M, Pascual F, Aresti S: Acarbose-induced severe hepatotoxicity. Lancet 349:698-699, 1997